Results 161 to 170 of about 34,307 (290)

Differential Impact of Pharmacokinetic and Pharmacodynamic Variability on Response to Combination Therapy

open access: yesPharmacology Research &Perspectives, Volume 14, Issue 4, August 2026.
ABSTRACT Interindividual variability (IIV) in drug response complicates both fixed‐dose design and individualized therapy. Understanding how pharmacokinetic (PK) and pharmacodynamic (PD) processes jointly shape this variability is essential, particularly in combination therapy, where multiple interacting pathways influence outcomes. This study employed
Kuteesa R. Bisaso   +3 more
wiley   +1 more source

Unintended Consequences of Life‐Saving Pharmaceutical Innovations: How HAART Led to the Resurgence of Syphilis

open access: yesHealth Economics, Volume 35, Issue 7, Page 1118-1130, July 2026.
ABSTRACT Syphilis, a sexually transmitted infection that can lead to serious health complications, was almost eliminated in the United States by 2000. But since then, its incidence began to increase, recently reaching a 60‐year peak. We suggest that the introduction of the highly active antiretroviral therapy (HAART) drug regimen, which transformed HIV
David Beheshti   +2 more
wiley   +1 more source

Structural basis of ligand selectivity in FAD/NAD(P)H‐dependent dehydrogenases: insights from trypanothione reductase and type II NADH dehydrogenase

open access: yesProtein Science, Volume 35, Issue 7, July 2026.
Abstract FAD/NAD(P)H‐dependent dehydrogenases form a structurally conserved family of redox enzymes that participate in essential metabolic processes across parasites and higher organisms. Among them, trypanothione reductase (TR) is a key component of the redox metabolism of Leishmania species and represents an attractive target for antileishmanial ...
Giulia Chiara Maria Perrone   +15 more
wiley   +1 more source

TARDBP as a regulator of HIV-1 assembly and infection: a review of targeting the viral capsid precursor Pr55Gag and limiting viral core entry. [PDF]

open access: yesCell Commun Signal
Cabrera-Rodríguez R   +9 more
europepmc   +1 more source

Health, Social and Recidivism Outcomes Among People Who Have Been Incarcerated in New South Wales, Australia: Study Protocol and Cohort Profile for the Prison Outcomes STudy (POST)

open access: yesDrug and Alcohol Review, Volume 45, Issue 5, July 2026.
ABSTRACT Introduction We have been funded to examine post‐incarceration health and social outcomes for all people incarcerated in New South Wales, Australia, 2000–2022; assess treatment and services for drug dependence and serious mental illness; and project the impact of expanding intervention coverage. We will use a linked cohort, the Prison Outcomes
Louisa Degenhardt   +19 more
wiley   +1 more source

The Safety Tether: How China Manages Civil Society Through Lawfare

open access: yesGovernance, Volume 39, Issue 3, July 2026.
ABSTRACT How do authoritarian regimes benefit from civil society organizations' expertise and capacity while mitigating the potential risks they pose? Using machine learning and interrupted time series modeling of an original custom‐annotated dataset of all historical NGO registrations in China, we find that NGO policy is unevenly implemented.
Timothy Hildebrandt, Blake Miller
wiley   +1 more source

Kinetics of HIV-1 Fusion Inhibition: Implications for Viral Resistance and the Design of Improved Fusion Inhibitors

open access: yes, 2009
HIV-1 entry into host cells is mediated by the trimeric envelope glycoprotein (Env). During the fusion process, two important regions of the gp41 transmembrane Env subunit are transiently exposed.
Kahle, Kristen M
core  

Home - About - Disclaimer - Privacy